The estimated Net Worth of Eric Hobbs is at least $6.2 Million dollars as of 11 May 2022. Dr Hobbs owns over 228,604 units of Berkeley Lights stock worth over $219,270 and over the last 4 years he sold BLI stock worth over $5,439,859. In addition, he makes $540,025 as CEO & Director at Berkeley Lights.
Dr has made over 9 trades of the Berkeley Lights stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 228,604 units of BLI stock worth $976,139 on 11 May 2022.
The largest trade he's ever made was exercising 266,198 units of Berkeley Lights stock on 17 August 2020 worth over $220,944. On average, Dr trades about 53,600 units every 40 days since 2020. As of 11 May 2022 he still owns at least 182,725 units of Berkeley Lights stock.
You can see the complete history of Dr Hobbs stock trades at the bottom of the page.
Dr. Eric D. Hobbs Ph.D. is the CEO & Director at Berkeley Lights.
As the CEO & Director of Berkeley Lights, the total compensation of Dr D at Berkeley Lights is $540,025. There are no executives at Berkeley Lights getting paid more.
Dr D is 43, he's been the CEO & Director of Berkeley Lights since . There are 4 older and no younger executives at Berkeley Lights. The oldest executive at Berkeley Lights, Inc. is Stuart L. Merkadeau, 60, who is the Gen. Counsel.
Eric's mailing address filed with the SEC is C/O BERKELEY LIGHTS, INC., 5858 HORTON STREET, SUITE 320, EMERYVILLE, CA, 94608.
Over the last 4 years, insiders at Berkeley Lights have traded over $204,033,733 worth of Berkeley Lights stock and bought 177,704 units worth $1,660,642 . The most active insiders traders include Michael E Marks, Gregory T Lucier und John R Chiminski. On average, Berkeley Lights executives and independent directors trade stock every 13 days with the average trade being worth of $83,843. The most recent stock trade was executed by James Paul Mc Claskey on 20 October 2022, trading 122 units of BLI stock currently worth $243.
Berkeley Lights, Inc., a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. It serves in North America, the Asia Pacific, and Europe. Berkeley Lights, Inc. was incorporated in 2011 and is headquartered in Emeryville, California.
Berkeley Lights executives and other stock owners filed with the SEC include: